Home > Analytics > METROPOLIS HEALTHCARE

METROPOLIS HEALTHCARE
Intrinsic Value | Fundamental Analysis

BOM : 542650     NSE : METROPOLIS    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Sep 27,2022
Price(EOD): ₹ 1,485.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Hospital & Healthcare Services
MCap: ₹ 7,606.53 Cr
Value of ₹ 1 Lac invested in METROPOLIS HEALTHCARE
on Apr 15,2019 (price: ₹ 959.55)

₹ 1 L

₹ 1.55 L

1W : 8.7% 1M : 4.7% 1Y : -51.9%
COMMUNITY POLL
for METROPOLIS HEALTHCARE
Please provide your vote to see the results
METROPOLIS HEALTHCARE is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Industry Peers & Returns1W1M1Y
METROPOLIS HEALTHCARE 8.7% 4.7% -51.9%
APOLLO HOSPITALS ENTERPRISE -7.9% 0.7% -16%
MAX HEALTHCARE INSTITUTE -5.4% 9.2% 12.4%
DR LAL PATHLABS 10.8% 0.2% -36.5%
FORTIS HEALTHCARE -16.8% -10.9% -4.7%
ASTER DM HEALTHCARE -1.1% 16.5% 10%
NARAYANA HRUDAYALAYA 0.3% 3.2% 26.1%
KRISHNA INSTITUTE OF MEDICAL SCIENCES 2.4% 14.4% 10.1%
THYROCARE TECHNOLOGIES 1.4% 11.3% -45.3%

FUNDAMENTAL ANALYSIS OF METROPOLIS HEALTHCARE

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 METROPOLIS is one of the top 18% companies with good fundamentals ! Discover More →

VALUATION OF METROPOLIS HEALTHCARE

 
Valuation Score
[As on : Sep 27,2022 ]

Ratio Consolidated
P/E
P/B
P/S
43.89
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 173.33 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

8.7
P/B Calculated based on Book Value of Rs 874.40 Cr
[Latest Year - Mar2022 - Consolidated Results ]

6.44
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,181.43 Cr
[Latest Qtr - Jun2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 METROPOLIS is one of the potential top 17% undervalued companies ! Discover More →

FAIR VALUE OF METROPOLIS HEALTHCARE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-19%
-33%
-33%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF METROPOLIS HEALTHCARE



METROPOLIS HEALTHCARE vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF METROPOLIS HEALTHCARE

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.32
0
0
0.11
0.3
0
0
0.1
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF METROPOLIS HEALTHCARE

Pledged Promoter Shares
1.18 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF METROPOLIS HEALTHCARE

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-8.51%
-8.49%
-24.15%
-16.4%
-14.35%
-33.1%
-58.45%
-55.2%
QtrlyTrend
-8
Latest Qtr: Jun2022
Quarterly Result Analysis →


METROPOLIS HEALTHCARE related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE -2.3% 0% -13.7%
S&P BSE 250 SMALLCAP -4.6% -1.2% -1.3%
S&P BSE 500 -4.8% -2.5% -1.6%
S&P BSE ALLCAP -4.8% -2.4% -1.2%
S&P BSE SMALL CAP -4.9% -1.2% 0.5%
NSE Indices1W1M1Y
NIFTY HEALTHCARE -1.2% 0.7% -12%
NIFTY 500 -4.8% -2.5% -1.8%
NIFTY 200 -4.8% -2.7% -2.1%
NIFTY500 MULTICAP 50:25:25 -4.9% -2.1% -1.1%
NIFTY LARGE MIDCAP 250 -5% -2.3% -0.2%

You may also like the below Video Courses


FAQ about METROPOLIS HEALTHCARE


Is METROPOLIS HEALTHCARE good for long term investment?

As on Sep 27,2022, the Fundamentals of METROPOLIS HEALTHCARE look Strong and hence it may be good for long term investment! See Financial Performance of METROPOLIS HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is METROPOLIS HEALTHCARE UnderValued or OverValued?

As on Sep 27,2022, METROPOLIS HEALTHCARE is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of METROPOLIS HEALTHCARE ?

As on Sep 27,2022, the Intrinsic Value of METROPOLIS HEALTHCARE is Rs. 2,201.35 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 1,842.36
Fair Value [Median EV / Sales Model] : Rs. 2,207.15
Fair Value [Median Price / Sales Model] : Rs. 2,201.35
Estimated Median Fair Value of METROPOLIS HEALTHCARE : Rs. 2,201.35

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is METROPOLIS HEALTHCARE trading at a Premium or Discount?

As on Sep 27,2022, METROPOLIS HEALTHCARE is trading at a Discount of -33% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].